In the present study, the estimated prevalence of lung fibrosis was calculated based on the positivity rates and positive predictive values of serum SP-D and KL-6, yielding estimates of 807.2 and 599.8 per 100,000 individuals, respectively. This evidence concerns the gene SFTPD and pulmonary fibrosis.